SBC Medical Group Holdings Incorporated reported fourth-quarter earnings that exceeded Wall Street expectations, with the cosmetic treatment center management company posting basic and diluted earnings of $0.14 per share versus the $0.12 consensus. The beat of 15.5% came despite a revenue decline, as the company demonstrated improved profitability across its operations in Japan, Vietnam, the United States, and Singapore. Net income reached $14.2M for the quarter, while EPS moved up 133.3% year-over-year from the $0.06 posted in Q4 2024.
The company generated $39.6M in revenue for the quarter, down 11.0% from the prior-year period. Revenue was down 10.9% from $44.4M in Q4 2024. The top-performing segment, revenues from related parties, generated $35.0M during the three-month period. Average revenue per customer came in at 316 dollars for the quarter.
SBC Medical Group operated 283 franchise locations at quarter end as it continues to expand its network of cosmetic treatment centers. The company’s shares trade on the NASDAQ, where analyst sentiment remains positive with Wall Street consensus standing at 5 buy, 1 hold, 0 sell ratings.
A detailed analysis of SBC Medical Group Holdings Incorporated’s quarter follows shortly on AlphaStreet.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.